Pharmafile Logo
Pharmafocus logo
Advanced Search

biologics

Showing 15 posts of 30 posts found.

Recipharm designates Germany site as Centre of Excellence

October 9, 2025
Research and Development CDMO, Cuxhaven, Recipharm, biologics

The multi-product facility recently underwent significant renovations

News

Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0

January 17, 2025
CPhI, Pharmpack, biologics, predictions

Biologic approvals, drug delivery advancements, GLP-1 generics and the long-sought funding return to drive a record year in 2025 13 …

News
Press release

Lonza to acquire biologics site in Vacaville, US from Roche for $1.2bn

March 20, 2024
Manufacturing and Production Lonza, Pharmacy, Roche, biologics, facility, manufacturing

Lonza has announced that it has signed an agreement to acquire the Genentech large-scale biologics site based in Vacaville, California, …

News

AstraZeneca to retire MedImmune brand amid restructuring

February 15, 2019
Medical Communications AstraZeneca, Business, MedImmune, R&D, biologics, restructuring

AstraZeneca is retiring the MedImmune brand as part of a restructuring that will see biologics integrated into two new R&D …

News
bi_microparts_image

Boehringer injects €230 million in new Biologicals Development Center

June 26, 2018
Manufacturing and Production Boehringer Ingelheim, biologics, manufacturing, pharma

Prominent industry player Boehringer Ingelheim has unveiled plans to invest €230 million into the construction of a new Biologicals Development …

News
abbvie_0

AbbVie adds biologic production capability to Singapore facility

October 4, 2017
Manufacturing and Production, Research and Development AbbVie, Singapore, biologics, pharma, pharmaceuticals

AbbVie has expanded the operational capability of its facility located at the Tuas Biomedical Park in Singapore with the addition …

News
foundry

UK’s first commercial synthetic biology foundry begins production

April 7, 2016
Manufacturing and Production, Research and Development Biological, biologics, foundry, synbicite

SynbiCITE’s has begun production at the UK’s first commercial synthetic biology foundry. The site provides automated end-to-end design, construction and …

News
FDA sign

FDA review for Sanofi and Regeneron’s biologic arthritis drug

January 8, 2016
Medical Communications, Sales and Marketing FDA, Regeneron, Sanofi, biologics, rheumatoid arthritis, sarilumab

The FDA has accepted for review a Biologics License Application (BLA) from Sanofi and Regeneron for the rheumatoid arthritis treatment …

News
AZ_scientist

AstraZeneca deal to delve into the secretome

December 11, 2015
Medical Communications, Research and Development AstraZeneca, MedImmune, biologics, secretome

MedImmune, the biologics research and development arm of pharma giant AstraZeneca, has signed a collaboration with Swedish universities and research …

News
Europe Member State flags

EU plans export waiver for pharma manufacturing

November 3, 2015
Manufacturing and Production EGA, European Commission, biologics, biosimilars, generics, manufacturing, supplementary protection certificates

The European Commission plans to bring in an export waiver for supplementary protection certificates, in order to boost pharma industry …

News
Coins

ANALYSIS: The challenges of forecasting biosimilar sales across Europe

October 29, 2015
Manufacturing and Production, Research and Development, Sales and Marketing biologics, biosimilars, generics, patent cliff, patents, sales, sales forecasts

The introduction of biologic medicines revolutionised treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases.The landscape …

Feature
astrazeneca image

AstraZeneca purchases former Amgen US facility

September 15, 2015
Manufacturing and Production Amgen, AstraZeneca, US, biologics, manufacturing, production

AstraZeneca has bolstered its US presence with the purchase of a high-tech biologics manufacturing facility from pharma rival Amgen. The …

News
BI image

Sanofi and Boehringer partner on biologics manufacturing

January 15, 2015
Manufacturing and Production, Sales and Marketing Boehringer, Sanofi, antibodies, biologics, cardiovascular, diabetes, mabs, manufacturing, monoclonal, oncology

Boehringer Ingelheim will help Sanofi extend its manufacturing capabilities for biologics in a new alliance, the companies have announced. Boehringer’s …

News
Samsung Incheon plant image

BMS expands Samsung deal

April 29, 2014
Manufacturing and Production BMS, Roche, Samsung, UCSF, biologics, incheon

Bristol-Myers Squibb has expanded its biopharmaceutical manufacturing agreement with South Korea’s Samsung BioLogics. Last year, Bristol-Myers Squibb signed a 10-year …

News

Biologics lift for UK

April 22, 2014
Manufacturing and Production, Sales and Marketing Cameron, UK, biologics, darlington, nbmc

Work has begun on a key new £38 million centre in Central Park, Darlington, which should increase the biologics capability …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025